Efficacy and safety of radiotherapy in first-line treatment for de novo advanced esophageal cancer in the era of immunochemotherapy: a systematic review and meta-analysis
Year: 2025
Type: review
Language: en
Topic: Esophageal Cancer Research and Treatment
Authors and affiliations:
raw_author_name: Hai Zeng
raw_affiliation_strings: Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, 434000, P.R. China
raw_author_name: Yan-Ling Wu
raw_affiliation_strings: Department of Radiation Oncology, Shenzhen Hospital, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, 518116, China
raw_author_name: Xiaofeng Wang
raw_affiliation_strings: Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section,, Chengdu, Sichuan Province, 610000, China
raw_author_name: Hui Bai
raw_affiliation_strings: Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi street, Hexi District, Tianjin, 300060, China
raw_author_name: Cihui Yan
raw_affiliation_strings: Department of Immunology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi Street, Hexi District, Tianjin, 300060, China. cihuiyan@tmu.edu.cn
Department of Immunology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi Street, Hexi District, Tianjin, 300060, China
raw_author_name: Wencheng Zhang
raw_affiliation_strings: Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi street, Hexi District, Tianjin, 300060, China. wczhang@tmu.edu.cn
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi street, Hexi District, Tianjin, 300060, China
raw_author_name: Qifeng Wang
raw_affiliation_strings: Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section,, Chengdu, Sichuan Province, 610000, China. wangqifeng@scszlyy.org.cn
Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section,, Chengdu, Sichuan Province, 610000, China